Embecta Corp. (EMBC)
Health Care / Health Care Equipment
S&P SmallCap 600$8.78
Scores poorly across most models. Proceed with caution.
Weak
Score based on 4 of 5 models — moderate confidence
Is Embecta Corp. a Good Investment in 2026?
Embecta Corp. (EMBC) scores 3.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates Embecta Corp. as Strong (Top half (rank 30%)). The Lynch model is the least favorable, rating it Neutral. Embecta Corp. ranks #863 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 5x earnings — near sector median of 25x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Attractive
Business quality & competitive moat
Graham
Attractive
Price vs intrinsic value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Strong
Top half (rank 30%)
Frequently Asked Questions
Is Embecta Corp. (EMBC) a good investment?
What is Embecta Corp.'s Piotroski F-Score?
Is EMBC overvalued or undervalued?
How does EMBC compare to other Health Care stocks?
What do investment models say about EMBC?
Similar Stocks
Compare EMBC with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer